Back to Archive

SensUs 2026

Parkinson's monitoring

Biomarker: Levodopa

The Theme

SensUs 2026 aims to track levodopa fluctuations through continuous monitoring. This will help personalize treatment for Parkinson's disease patients and make a step towards closed-loop levodopa therapy!

The Teams

A-levo

A-levo

McGill University

Aixsense

Aixsense

RWTH Aachen

BarceL-DOPA

BarceL-DOPA

Universitat Politècnica de Catalunya

BiosensUM

BiosensUM

Université de Montréal & Polytechnique Montréal

Biosense EPFL

Biosense EPFL

EPFL

Biosensing Team Twente

Biosensing Team Twente

University of Twente

DeTectUs

DeTectUs

Technical University of Denmark

G-Pulse

G-Pulse

Istanbul Technical University

GlaSense

GlaSense

University of Glasgow

MakeSense

MakeSense

ShanghaiTech University

Munich Bioneers

Munich Bioneers

Technical University of Munich

ParisBiotek

ParisBiotek

Institut Polytechnique de Paris

SensETH

SensETH

ETH Zürich

SensTech

SensTech

Cornell University

SenseNC

SenseNC

North Carolina State University

TUcanSense

TUcanSense

TU Darmstadt

TruSense

TruSense

Zhejiang University

UCTeam

UCTeam

University of Chemistry and Technology, Prague